Establishment and evaluation of a transgenic mouse model of arthritis induced by overexpressing human tumor necrosis factor alpha

Biology Open

Volumn 5, Issue 4, 2016, Pages 418-423

  Li, Ge ^a   Wu, Yu?e ^a   Jia, Huanhuan ^a   Tang, Lu ^a   Huang, Ren ^a   Peng, Yucai ^a,b   Zhang, Yu ^a  

^a Guangdong Provincial Key Laboratory of Agro Animal Genomics Molecular Breeding   (China)

^b Livzon MabPharm Inc   (China)

Author keywords

Animal model; Drug evaluation; Rheumatoid arthritis; Synovial hyperplasia; TNF ; Transgenic

Indexed keywords

ADALIMUMAB; AT 132; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; BRAIN TISSUE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HYPERPLASIA; JOINT SWELLING; KIDNEY PARENCHYMA; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; POLYARTHRITIS; PRIMARY PREVENTION; RHEUMATOID ARTHRITIS; SYNOVIUM; TRANSGENIC MOUSE;

EID: 84978394045     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.016279     Document Type: Article

References (19)

1. Backlund, J., Li, C., Jansson, E., Carlsen, S., Merky, P., Nandakumar, K.-S., Haag, S., Ytterberg, J., Zubarev, R. A. and Holmdahl, R. (2013). C57BL/6 mice need MHC class II Aq to develop collagen-induced arthritis dependent on autoreactive T cells. Ann. Rheum. Dis. 72, 1225-1232.
2. Butler, D. M., Malfait, A. M., Mason, L. J., Warden, P. J., Kollias, G., Maini, R. N., Feldmann, M. and Brennan, F. M. (1997). DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J. Immunol. 159, 2867-2876.
3. Gravallese, E. M., Manning, C., Tsay, A., Naito, A., Pan, C., Amento, E. and Goldring, S. R. (2000). Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43, 250-258.
4. Han, J., Brown, T. and Beutler, B. (1990). Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171, 465-475.
5. Hayward, M. D., Jones, B. K., Saparov, A., Hain, H. S., Trillat, A.-C., Bunzel, M. M., Corona, A., Li-Wang, B., Strenkowski, B., Giordano, C. et al. (2007). An extensive phenotypic characterization of the hTNFalpha transgenic mice. BMC Physiol. 7, 13.
6. Holmdahl, R., Jansson, L., Andersson, M. and Larsson, E. (1988).Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritisImmunology65305-310Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology 65, 305-310.
7. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D. and Kollias, G. (1991). Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025-4031.
8. Kruys, V., Marinx, O., Shaw, G., Deschamps, J. and Huez, G. (1989).Translational blockade imposed by cytokine-derived UA-rich sequencesScience245852-855Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245, 852-855.
9. Lee, D. M. and Weinblatt, M. E. (2001). Rheumatoid arthritis. Lancet 358, 903-911.
10. Li, P. and Schwarz, E. M. (2003). The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin. Immunopathol. 25, 19-33.
11. Mcinnes, I. B. and Schett, G. (2011). The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205-2219.
12. Monaco, C., Nanchahal, J., Taylor, P. and Feldmann, M. (2015). Anti-TNF therapy: past, present and future. Int. Immunol. 27, 55-62.
13. Osman, G. E., Hannibal, M. C., Anderson, J. P., Lasky, S. R., Ladiges, W. C. and Hood, L. (1999). FVB/N (H2(q)) mouse is resistant to arthritis induction and exhibits a genomic deletion of T-cell receptor V beta gene segments. Immunogenetics 49, 851-859.
14. Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F. and Schett, G. (2002). Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110, 1419-1427.
15. Sack, U., Gu?nther, A., Pfeiffer, R., Genest, M., Kinne, J., Biskop, M., Ka?mpfer, I., Krenn, V., Emmrich, F. and Lehmann, J. (1999). Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice (human/murine SCID arthritis). J. Autoimmun. 13, 335-346.
16. Takayanagi, H., Oda, H., Yamamoto, S., Kawaguchi, H., Tanaka, S., Nishikawa, T. and Koshihara, Y. (1997). A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem. Biophys. Res. Commun. 240, 279-286.
17. Taylor, P. C. (2010). Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr. Opin. Pharmacol. 10, 308-315.
18. Williams, R. O., Feldmann, M. and Maini, R. N. (1992). Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89, 9784-9788.
19. Yang, J., Zhang, L., Yu, C., Yang, X.-F. and Wang, H. (2014). Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2, 1.